412 results on '"McFadden, Eugene"'
Search Results
52. Rationale and methods of the integrated biomarker and imaging study (IBIS): Combining invasive and non-invasive imaging with biomarkers to detect subclinical atherosclerosis and assess coronary lesion biology
53. Coronary stenting in small vessels
54. Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials
55. Multislice spiral computed tomography coronary angiography in patients with stable angina pectoris
56. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions
57. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure
58. NO synthesis is involved in structural and functional effects of ACE inhibitors in injured arteries
59. Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction
60. No change in endothelial-dependent vasomotion late after coronary irradiation
61. Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease
62. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina
63. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
64. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
65. TCT-423 Periprocedural Myocardial Infarction Is Associated With Mortality in Stable Angina Pectoris Patients Undergoing Elective Coronary Intervention
66. Randomised evaluation of a novel biodegradable polymer-based sirolimus-eluting stent in ST-segment elevation myocardial infarction: the MASTER study
67. CORE LABORATORY ASSESSMENT OF NON-FATAL Q-WAVE MYOCARDIAL INFARCTION IN THE GLOBAL LEADERS TRIAL: METHODS AND FINDINGS
68. Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY)
69. effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients
70. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study
71. Why do beta-blockers help in idiopathic dilated cardiomyopathy-frequency mismatch?
72. Six-month quantitative angiographic follow-up of <50% diameter stenoses dilated during multilesion percutaneous transluminal coronary angioplasty
73. Serotonin and Coronary Artery Disease
74. Prognostic value of changes in R-wave amplitude during exercise testing after a first acute myocardial infarction
75. Effectiveness of multiple bolus administration of tissue-type plasminogen activator in acute myocardial infarction
76. Reply
77. Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI)
78. IMPACT OF PERIPROCEDURAL MYOCARDIAL BIOMARKER ELEVATION ON MORTALITY FOLLOWING PERCUTANEOUS CORONARY INTERVENTION: A POOLED PATIENT-LEVEL (N=13452) ANALYSIS OF CONTEMPORARY STENT TRIALS
79. Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials
80. Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials
81. Emergent Unilateral Renal Artery Stenting for Treatment of Flash Pulmonary Edema: Fact or Fiction?
82. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vsaspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
83. Endovascular treatment for dissection of the descending aorta
84. Coronary Atherosclerosis : Current Management and Treatment
85. Graft failure prior to discharge after coronary artery bypass surgery: a prospective single-centre study using dual 64-slice computed tomography
86. Reply: Following Renal Outcomes With Staging in Percutaneous Coronary Intervention Trials
87. 'A successful case of emergent unilateral renal artery stenting to treat flash pulmonary edema'
88. Proposed standardized neurological endpoints for cardiovascular clinical trials.
89. Anaphylaxis from Wasp Stings Inducing Coronary Thrombus
90. Cocaine-Associated Myocardial Infarction: Should They All Be Stented?
91. Clinical Aspects of Acute Coronary Syndromes
92. Quantification of scientific output in cardiovascular medicine: a perspective based on global data
93. Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial.
94. TCT-13 Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents
95. Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: Methodology and external validation
96. Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial
97. Clinical event committees in coronary stent trials: insights and recommendations based on experience in an unselected study population
98. Everolimus-eluting stents and paclitaxel-eluting stents in patients presenting with myocardial infarction: insights from the two-year results of the COMPARE prospective randomised controlled trial
99. Vulnerable plaque: From bench to bedside; local pacification versus systemic therapy
100. Lumen enhancement influences absolute noncalcific plaque density on multislice computed tomography coronary angiography: ex-vivo validation and in-vivo demonstration
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.